Our studies reveal a fourth resistance mechanism, in which cabozantinib induces the secretion of a spectrum of proteins, e.g. PAPPA and IGFBP2 that are known to increase tumorigenic properties of PCa cells, from osteoblasts to increase the survival and migration of tumor cells. This evidence concerns the gene IGFBP2 and posterior cortical atrophy.